Evaluation of the Safety and Efficacy of the Respiratory Syncytial Virus FG Chimeric Vaccine KD-409 in Rodent Models for Maternal and Pediatric Vaccination. [PDF]
Vaccines (Basel)Yamaue R +3 more
europepmc +1 more source
Role of plant expression systems in antibody production for passive immunization.
International Journal of Developmental Biology, 2013 V. Virdi, A. Depicker
semanticscholar +1 more source
Animal models of antiphospholipid syndrome. [PDF]
Front ImmunolRen C, Li H, Ren T.
europepmc +1 more source
Early maternal tenofovir treatment and infant vaccination: a scalable model for hepatitis B virus mother-to-child transmission control in resource-limited areas. [PDF]
Transl Gastroenterol HepatolIslam MD, Coffin CS.
europepmc +1 more source
Effectiveness of Maternal Respiratory Syncytial Virus Vaccination in Conferring Infant Immunity: Review and Future Perspectives. [PDF]
Vaccines (Basel)Kaneko M, Muraoka J.
europepmc +1 more source
Low maternal pertussis protection and quantified infant risk: supporting maternal Tdap vaccination in China. [PDF]
Front ImmunolWang W, Zhang T, Sun X.
europepmc +1 more source
Prophylactic monoclonal antibodies against respiratory syncytial virus in early life: An in-depth review of mechanisms of action, failure factors, and future perspectives. [PDF]
Pediatr Allergy ImmunolBizot E +5 more
europepmc +1 more source
Introducing the Concept of Small Vulnerable Newborns (SVN) as an Additional Endpoint to Evaluate Birth Outcomes in the Context of RSV Immunization Studies-A Commentary. [PDF]
Influenza Other Respir VirusesGerstenberg J +2 more
europepmc +1 more source
A lipid nanoparticle encapsulated CPA-CTD mRNA vaccine provides protection against <i>Clostridium perfringens</i>-driven diseases. [PDF]
Front ImmunolJia Q +9 more
europepmc +1 more source